Combretastatin A-1
From Wikipedia, the free encyclopedia
Combretastatin A-1 | |
---|---|
IUPAC name 3-Methoxy-6-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]benzene-1,2-diol | |
Other names Combretastatin A1; OXi4500 | |
Identifiers | |
CAS number | 109971-63-3 |
PubChem | 6078282 |
ChemSpider | 4800178 |
ChEMBL | CHEMBL520204 |
Jmol-3D images | Image 1 |
| |
| |
Properties | |
Molecular formula | C18H20O6 |
Molar mass | 332.35 g mol−1 |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Combretastatin A-1 is a combretastatin and a stilbenoid. It can be found in Combretum caffrum, the Eastern Cape South African Bushwillow tree.[1]
It is an antiangiogenic agent acting by destabilizing tubulin, which induces cell apoptosis of proliferating endothelial cells.[1]
Currently designated an orphan drug by the FDA, combretastatin A1 diphosphate (OXi4503) is in Phase I clinical trials. [2]
References
- ↑ 1.0 1.1 Pettit, G. R.; Singh, S. B.; Niven, M. L.; Hamel, E.; Schmidt, J. M. (1987). "Isolation, Structure, and Synthesis of Combretastatins A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Derived from Combretum caffrum". Journal of Natural Products 50 (1): 119–131. doi:10.1021/np50049a016. PMID 3598594.
- ↑ http://clinicaltrials.gov/ct2/show/NCT01085656
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.